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Abstract.  We have distinguished five TNF-ot-inducible 
cell adhesion mechanisms on microvasculature-derived 
endothelioma cells of the mouse which mediate the 
binding of different types of leukocytes. Three of these 
mechanisms could be identified as the mouse homo- 
logs of ICAM-1, VCAM-1, and E-selectin, of which 
the latter was defined by the novel mAb 21KC10.  The 
fourth TNF-ot-inducible cell adhesion mechanism was 
blocked by antibodies specific for mouse P-selectin. 
We have recently shown that TNF-ot stimulates the 
synthesis of P-selectin in mouse endothelioma cells 
(A. Weller, S.  Isenmann, D. Vestweber.  1992. J.  Biol. 
Chem.  267:15176-15183).  Here we show that this 
stimulation leads to maximal cell surface expression 
levels within 4  h after stimulation while the same en- 
dothelioma cells are also able to upregulate P-selectin 
at the cell surface within minutes after stimulation 
with PMA.  Both effects are additive. 
The fifth TNF-induced cell adhesion mechanism is 
defined by mediating the binding to the mouse mono- 
cyte/macrophage cell line J774.  This adhesion mecha- 
nism is not inhibited by antibodies against any of the 
other four CAMs; it functions well at 7°C  (in contrast 
to ICAM-1 and VCAM-1)  and it is as active after 16 h 
of TNF induction as after 4 h  (in contrast to E- and 
P-selectin). Furthermore, this new adhesion mecha- 
nism only functions on two of three endothelioma cell 
lines and is undetectable on the third, although 
ICAM-1, VCAM-1, E-selectin, and P-selectin could be 
demonstrated to function well on this cell line. Thus, 
in addition to the three known TNF-inducible CAMs, 
ICAM-1, VCAM-1, and E-selectin, also P-selectin and 
a  fifth, as yet molecularly undefined cell adhesion 
mechanism, are TNF inducible at the cell surface of 
mouse endothelioma cells. 
M 
IGRATION across the blood vessel wall is a  pre- 
requisite for leukocytes to mediate host defense 
mechanisms at sites of bacterial invasion or tissue 
damage. The central step in this migration process is the 
adhesion of leukocytes to activated endothelial cells lining 
the venules of such inflamed tissues. Cytokines and other 
inflammatory mediators  induce  cell  adhesion  molecules 
(CAMs)  ~  on the surface of activated endothelial cells which 
allow leukocytes to recognize sites of inflammation and to 
bind to the blood vessel wall (Osborn, 1990). This adhesion 
process has been proposed to be based on a cascade of mo- 
lecular interactions (Butcher,  1991; Shimizu et al.,  1992) 
and is mediated by multiple pairs of CAMs. 
The selectins (Bevilacqua et al.,  1991) are at present the 
best candidates for CAMs which function very early in the 
cell binding process and may even mediate the initial cell 
contact. Two of them, E- and P-selectin, are expressed on 
endothelial  cells  (Bevilacqua  et  al.,  1989;  Geng  et  al., 
1.  Abbreviations  used  in  this  paper:  CAM,  cell  adhesion  molecule; 
HUVEC, human umbilical vein endothelial cell; PCR, polymerase chain 
reaction; PMN, polymorphonuclear granulocytes. 
1990),  the third, L-selectin, is expressed on all leukocytes 
(Siegelman et al.,  1989;  Camerini et al.,  1989).  Antibody 
blocking studies have demonstrated, in vivo, that L-selectin 
is involved in "leukocyte-rolling" on the blood vessel wall 
which describes the initial, transient interactions of leuko- 
cytes with the surface of endothelial cells (von Andrian et 
al.,  1991). This  could also be  the  function of P-selectin 
which is stored in intracellular granula and is the most rap- 
idly inducible endothelial CAM. It is transported to the cell 
surface within minutes upon stimulation by pre-inflamma- 
tory mediators, such as thrombin and histamine (Geng et al., 
1990).  For  this  selectin,  binding  to  polymorphonuclear 
granulocytes (PMNs, neutrophils) in vitro could be demon- 
strated under shearing forces resembling those in flowing 
blood, while another endothelial CAM, ICAM-1, could only 
support  PMN  binding under  static  incubation conditions 
(Lawrence and Springer, 1991). In agreement with this, anti- 
bodies against CD18 (Mac-i) did not inhibit leukocyte rolling 
(von Andrian et al.,  1991). Based on these in vitro and in 
vivo data, the selectins have been proposed to function as 
"rolling receptors" while ICAM-1  is probably essential for 
©  The Rockefeller University  Press, 0021-9525/93/05/655/10  $2.00 
The Journal of Cell Biology, Volume 121, Number 3, May 1993 655-664  655 leukocyte  binding  at  a  later  stage  in  the  cell  adhesion 
process. 
In addition to mediating different molecular steps in the 
adhesion process, a variety of endothelial leukocyte recep- 
tors is necessary to allow the fine regulation of the extravasa- 
tion of different categories of leukocytes. E- and P-selectin 
support the binding of PMNs and monocytes (Larsen et al., 
1989; Geng et al.,  1990; Bevilacqua et al.,  1987) and also 
of certain  subsets  of lymphocytes  (Picker  et  al.,  1991; 
Shimizu et al.,  1991; Damle et al.,  1992). ICAM-1 binds to 
a  larger repertoire of leukocytes including PMNs,  mono- 
cytes, and lymphocytes (Kishimoto et al.,  1989). VCAM-1 
which is, like ICAM-1, also a member of the immunoglobu- 
lin super-gene family, mediates the binding of lymphocytes 
and monocytes, but not of PMNs to endothelial cells (Os- 
born et al.,  1989). 
All these endothelial CAMs are inducible at the surface of 
endothelial cells partly by different mechanisms and with 
different kinetics. On cultured human umbilical vein endo- 
thelial cells (HUVECs), the synthesis of ICAM-1,  VCAM-1, 
and E-selectin was found to be stimulated by TNF-c~ and IL- 
1/$ (Osborn, 1990). In addition, -y-IFN was shown to stimu- 
late the expression of ICAM-1  (Pober et al.,  1986) and IL-4 
was found to induce the expression of VCAM-1  (Thornhill 
et al.,  1990). The kinetics of expression differs: E-selectin 
is rapidly induced with maximal expression levels at the cell 
surface 3-4 h after stimulation by TNF-ct and is down regu- 
lated within the next 20 h (Bevilacqua et al.,  1987). In con- 
trast,  cell  surface  expression  of  ICAM-1  and  VCAM-1 
reaches maximal levels 4-6 h  after TNF-a induction and 
these levels are maintained for more than 48 h (Dustin and 
Springer,  1991;  Osborn,  1990).  For P-selectin,  only the 
thrombin and histamine induced transport regulation, which 
acts within minutes, has been described on HUVECs. 
In this report we have used various mouse endothelioma 
cell lines derived from microvasculature of different tissues 
(Williams et al., 1988) in order to search for TNF-inducible 
endothelial leukocyte adhesion molecules. We show,  using 
cell adhesion assays, that in addition to ICAM-1,  VCAM-1, 
and E-selectin, two more leukocyte adhesion mechanisms 
are TNF inducible at the surface of endothelial cells.  We 
found recently that the synthesis of P-selectin, similar to that 
of E-selectin, is TNF inducible in mouse endothelioma cells 
(Weller  et  al.,  1992).  Here  we  report,  that  this  TNF- 
induction leads to functionally detectable P-selectin at the 
cell surface and demonstrate that mouse endothelioma cells 
regulate the transport to the cell surface as well as the synthe- 
sis  of P-selectin.  The  fifth  TNF-inducible  cell  adhesion 
mechanism which we found on mouse endothelioma cells, 
mediates the binding of the mouse monocyte/macrophage 
cell line J774 and is not identical with any of the other four 
TNF-inducible CAMs. 
Materials and Methods 
Ce//s 
The mouse endothelioma cell lines sEnd.1 and eEnd.2 (Williams et al., 
1988) as well as bEnd.3 (W. Risau, Max-Planck-Institute for Physiological 
and Clinical Research, Bad Nauheim, Germany, and L. Williams, Ludwig 
Institute for Cancer Research, Melbourne, Australia) had been established 
from  polyoma-induced hemangiomas  in  skin  (sEnd.l),  in  the  embryo 
(eEnd.2), and in brain (bEnd.3) and were grown in DME with 10% FCS. 
The mouse T cell lymphoma TK-I and the B cell lymphoma LI-2 were both 
obtained from Dr. Bernhard Holzmann (Klinikurn rechts der Isar, Miinchen, 
Germany) and cultured in RPMI, with 10% FCS and 20 #M ~-mereapto- 
ethanol. 
The human monocytic HL60 and mouse monocytic J774 cells were pur- 
chased from American Type Culture Collection (Rockville, MD) and cul- 
tured in DME with 10% FCS, as were the mouse myeloma cells SP2/0 and 
J558. PMNs were freshly isolated from the femurs of 10-wk old NMRI mice 
by flushing out the bone marrow cells with cold PBS, using a syringe and 
a 23  g needle. The cell suspension was filtered through a nylon tissue. 
Antibodies 
The rat mAb YN1/1 against mouse ICAM-1  (MALA-2; Takei,  1985) was 
kindly provided by Dr. Fumio Takei (Vancouver) and the rat mAb MK-2 
against mouse VCAM-1 (Miyake et al., 1991) was a generous gift from Dr. 
Paul Kincade (Oklahoma Medical Research Foundation, Oklahoma City, 
OK) and was later produced from the American Type Culture Collection 
CRL  1909  hybridoma.  The  hybridoma  RI-2  (Holzmann  et  al.,  1989) 
producing a rat rnAb against the integrin chain a4 was obtained from Dr. 
Bernhard Holzmann. The anti-mouse CD44 mAb KM201  (Miyake et al., 
1990) was produced from the ATCC rat hybridoma TIB240 and the anti- 
CDlla  mAb M17/4.4.11.9  (Sanchez-Madrid et ai.,  1982)  and  the anti- 
CDllb mAb MI/70.15.11.5HL  (Springer et ai., 1978) were produced from 
the ATCC rat hybridomas TIB 217 and TIB 128, respectively. The rat mAb 
MECA 32, recognizing an endothelial specific antigen, was produced from 
a hybridoma which was kindly provided by Dr. Eugene Butcher (Stanford 
University School of Medicine, Palo Alto, CA). 
mAbs against TNF-inducible endothelial cell surface antigens were pro- 
duced by immunizing Lewis rats with bEnd.3 or sEnd.1 cells that had been 
treated  with  200  U/ml  human  recombinant  TNF  (which  was  kindly 
provided by the Knoll AG, Ludwigshafen, Germany), 3 or 16 h befure im- 
munization. Cells were injected four times (subcutaneously, with 2  x  107 
cells per injection) with 3-wk-intervals in PBS and 30% Alu-gei-s (Serva, 
Heidelberg, Germany) as adjuvants. 5 d after the last boost, spleen cells 
were fused with the mouse myeloma SP2/0 essentially as described (Vest- 
weber and  Kemler,  1985).  Hybridoma  supernatants  were differentially 
screened for indirect immunoperoxidase staining on TNF activated and 
non-activated endothelioma cells (see cell surface ELISA, described be- 
low).  Hybridomas  which  produced  antibodies  that  recognized  TNF- 
inducible cell surface antigens, were subcloned by limiting dilution. The 
polyclonal  rabbit  antiserum  against  a  peptide  containing  the  COOH- 
terminal 17 amino acids of mouse ELAM-1 has been described (Weller et 
al., 1992). An anti-mouse P-selectin rabbit antiserum was produced by im- 
munizing the purified P-selectin-immunoglobulin chimeric protein (de- 
scribed below) at 200 #g per injection. Specific antibodies were affinity 
purified on the fusion protein, conjugated to CNBr-sepharose (Pharmacia, 
Uppsala, Sweden). Antibodies against the Fc part of human IgG were re- 
moved by a second CNBr-sepharose column with conjugated human IgG 
(Sigma Immunochemicais, St. Louis, MO). 
Monovalent F(alY) fragments of mAbs were generated as described (Jon- 
ston and Thorpe,  1982). 
Selectin-Immunoglobulin Chimeric Proteins 
The 5' part of  the cDNAs of mouse P-selectin and mouse E-selectin, coding 
for the signal sequence, the lectin domain, the EGF-repeat and the first two 
complement  binding domains, were amplified by polymerase chain reaction 
(PCR) using oligonuclcotides which introduced a splice donor site at the 
3' end of the PCR fragment. The 3' end of the selectin cDNA fragments was 
defined by nucleotides A and G found in position 969 and 970 of mouse 
P-selectin cDNA (Weller et al.,  1992) and in position 1039 and 1040  of 
mouse E-selectin eDNA (Weller et ai., 1992). These two nucleotides repre- 
sented the first half of  the introduced splice donor site (AG'GT). In two sep- 
arate experiments, each of the two fragments was placed into an intron of 
the genomic sequence of the human IgGl heavy chain. This intron immedi- 
ately preceded the exon coding for the hinge region which was followed by 
the exons for the CH2 and CH3 domains. Construction was done by using 
the CD4-IgG expression plasmid pCD4-Hgl CE1 (provided by Dr. Klaus 
Karjalainen,  Basel Institute fur Immunology, Basel,  Switzerland; Trau- 
necker et al.,  1991) and replacing the CD4 sequences with the respective 
selection PCR fragment. Both PCR fragments were completely sequenced 
and no point mutations were found. The resulting plasmids were co-trans- 
fected together with a pSV-nco-plasmid  by electroporation into the myeloma 
cell J558.  3  x  106 electroporated cells were plated on six 96-well plates 
and the supernatant of G418-resistant clones was tested in enzyme-linked 
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directed against human IgG (dianova)  were coated on to the ELISA plates, 
the protein binding capacity of the plastic was blocked with 10% FCS, and 
after one hour incubation with the myeloma supernatants, bound fusion pro- 
teins were detected with peroxidase conjugated goat F(ab)2  anti-human 
IgG (dianova). Positive clones were subcloned twice by limiting dilution. 
The selectin IgG chimeric proteins were purified from the 10x concen- 
trated culture medium (DME,  10%  FCS) with protein A-sepharose and 
bound proteins were eluted with 0.1 M glycin/HCl, pH 3.0; followed by im- 
mediate neutralization with 50 mM Tris, pH 8.5. 
Cell Surface ELISA 
Endothelioma cells were plated at a density of 2  ×  104 cells per well in 96- 
well microtiter plates 2 d before the assay. Immediately before the test, the 
plates were cooled on ice for  15  rain, and then the adherent cells were 
washed three times with ice-cold PBS/Ca  2+ (containing 1 mMCaC12) and 
incubated with 100 #1 of ice-cold hybridoma supernatant or other antibody 
solutions in DME/10% FCS on ice for 1 h. The antibody solution was re- 
moved by aspiration and the cells were washed three times with ice-cold 
PBS/Ca  2+  and  fixed  for  30  rain  at  4"C  in  4%  paraformaldehyde  in 
PBS/Ca  2+. After removal of the fixative and three washes with PBS/Ca  2+, 
the cells were incubated for 1 h at room temperature with peroxidase con- 
jugated goat F(ab)2 anti-rat IgG (or anti-rabbit IgG, both dianova) diluted 
1/2,000  in  DME/10%  FCS.  The staining reaction was done in 50 mM 
K2HPO4,  25 mM citric acid, pH 6.0, with 300/~g/ml orthophenylendia- 
mine and 0.006% H202, and stopped by addition of HC! (final concentra- 
tion 1 M). The signals were quantified by measuring light absorbance at 492 
nm with an automated ELISA reader from SLT-Labinstruments (Vienna, 
Austria). 
Cell-surface ELISA signals for the selectins were standardized by com- 
parison with ELISA signals on the purified E-selectin-IgGt and P-selec- 
tin-IgGl  fusion proteins.  Highly  activated 96-well  ELISA plates  (ICN 
Radiochemicals) were coated with 5  tzg/ml  goat F(ab)2  anti-human IgG 
(dianova), blocked with 10% FCS in PBS, and incubated with serial 1/2 di- 
lutions of the purified fusion proteins ranging from 200 ng/ml to 0.1 ng/ml 
overnight at  room  temperature.  Antibody  incubations  were  done  with 
21KCI0 culture supernatant or 300 ng/ml affinity-purified rabbit antibodies 
against P-selectin-IgG1, followed by incubation with peroxidase-conjugated 
goat F(ab)2  anti-rat or anti-rabbit IgG.  These incubations as well as the 
subsequent staining reaction were done in parallel with the cell-surface 
ELISA under identical conditions. 
Cell Adhesion Assays 
Endothelioma cells were plated at a density of 2  x  104 cells per well on 
96-well microtiter plates 2 d before the test. For tests at 7°C, these adherent 
cells were washed twice in HBSS (Biochrom) at 7"C and placed at 7°C. 
Leukocytes were harvested, washed once in 7°C HBSS, and 5  x  105 cells 
were added in 100 #1 per well to the microtiter plate which was rotating 
at 75 rpm (with 1-cm diam of orbit). After a 20-rain incubation at 7°C un- 
bound leukocytes were removed by gently flicking them off. Bound cells 
were fixed with 1% glutaraldehyde in PBS for 2-3 h at 7°C, usually followed 
by three more washes with HBSS. For assays at 37°C, cells were washed 
in HBSS at room temperature before the incubation which was done on a 
shaker at 37°C. Bound cells were quantitated in triplicate by counting five 
different fields per well under the microscope. In alternative assays, un- 
bound cells were removed by centrifugation. For this, the wells were com- 
pletely filled with HBSS after a  20-rain cell-binding period, cautiously 
sealed with tape (plate sealers; Titertek Elfab a, Finland) avoiding any air 
bubbles and centrifuged upside down for 5 min at 500 rpm. Unbound cells 
were removed with the sealing tape. Quantitative analysis of these assays 
gave comparable results for both washing conditions with a slightly more 
even distribution  of bound  cells  after  washing  with  the  centrifugation 
method. 
lmmunoprecipitation and Immunoblot 
Immunoprecipitations and immunohlots were done as described (Weller et 
al., 1992).  In immunoprecipitations with rat mAbs usually 10 ml of hybrid- 
oma supernatant was incubated for 2 h with 20 #1 of protein A-sepharose 
(Pharmacia) to which 10/~g of affinity-purified rabbit IgG anti-rat IgG (di- 
anova) had been previously bound.  The antibody loaded beads were re- 
moved from the culture supernatant, washed three times with PBS, added 
to cell lysates of metabolically labeled cells, and further processed as de- 
scribed (Weller et al.,  1992). 
Results 
J774 Cells Bind to TNF-stimulated sEnd.l and bEnd.3 
Cells, but Not to TNF-stimulated eEnd.2 Cells 
We analyzed the ability of three mouse endothelioma cell 
lines eEnd.2, sEnd.l, and bEnd.3 to support leukocyte bind- 
ing after stimulation with TNF-ct. J774 mouse histiocytic 
cells were incubated with monolayers of the endothelioma 
cells that had been induced for 4 and 16 h with human recom- 
binant TNF-a. The assay was carried out at 7°C for 20 min 
under continuous shaking (75 rpm) in microtiter plates. Un- 
der these conditions, J774 cells did not bind to either of the 
endothelioma cell lines in the absence of TNF-a (Fig.  1). 
Strong binding was observed to sEnd.1 and bEnd.3 cells af- 
ter 4 h as well as after a  16-h treatment with TNF-ot.  How- 
ever, the same treatment did not stimulate eEnd.2 cells to 
bind to J774 (Fig. 1 B). This prompted us to examine, which 
of the known TNF-inducible CAMs originally found on hu- 
man  endothelial  cells  were  active  on  the  three  different 
mouse endothelioma cells. 
In addition to VCAM-1, ICAM-1,  and E-selectin, we also 
had to include P-selectin in this analysis, since we found re- 
cently that TNF-c~ also stimulates the synthesis of P-selectin 
in mouse endothelioma cells 0Veller et al.,  1992). To ana- 
lyze the kinetics of the TNF-induced cell surface expression 
and the accompanying cell adhesion function, the published 
mAbs MK-2 against VCAM-1  and YN  1/1 against ICAM-1 
could be used, while adhesion-blocking antibodies against 
mouse E- and P-selectin had first to be produced as described 
below. 
Generation of  Adhesion-blocking Antibodies against 
Mouse E- and P-selectin 
A mAb against mouse E-selectin was produced by immuniz- 
ing rats with intact sEnd.1 cells, which had been treated with 
human recombinant TNF-ot, 4 h before injection. Antibodies 
were  screened by  indirect immunoperoxidase staining  in 
"cell surface ELISA" assays for their ability to bind to anti- 
gens expressed only on the surface of TNF-treated send.1 
cells, but not on the surface of untreated sEnd.1 cells. A rat 
hybridoma was selected and subcloned, which produces the 
mAb 21KC10 which stains the cell surface of intact sEnd.1 
cells only after TNF treatment of the cells. In immunopre- 
cipitations of cell lysates from psS]methionine/[3sS]cysteine 
labeled, activated bEnd.3 cells, 21KC10 recognized an anti- 
gen (Fig. 2 A, lane 3) of identical electrophoretic mobility 
as mouse E-selectin which was detected with a polyclonal 
antibody (Fig. 2 A,  lane 1) against a peptide covering the 
COOH-terminal 17 amino acids of mouse E-selectin (Weller 
et al.,  1992). 
The identification of  the 21KC10 antigen as mouse E-selec- 
tin was further analyzed by testing the reactivity of  the 21KC10 
antibody with a recombinant fusion protein containing the 
lectin domain, the EGF repeat and the first two complement 
binding domains of mouse E-selectin fused to the hinge do- 
main of human IgG1 heavy chain. Fig. 3 demonstrates that 
the binding of 21KC10 to this chimeric protein in immuno- 
blots is due to the E-selectin part in this protein, since an 
analogous CD4-IgG~  chimeric protein and also human IgG 
were not detected. A  similarly constructed P-selectin-IgG~ 
chimeric protein was also not bound by 21KC10, which ex- 
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cells.  J774 cells  were incubated at 7°C with untreated  and  16 h 
TNF-activated endothelioma cells in 96-well microtiter plates.  (A) 
Phase contrast micrograph of two representative  wells  with un- 
treated and  16 h TNF-treated bEnd.3 cells after incubation with 
J774 cells and three washes with HBSS. (B) Adhesion of J774 cells 
to bend.3,  sEnd.l, and eEnd.2 cells  was quantitated  by counting 
adherent cells under the microscope at five defined areas per incu- 
bation well. Each measurement was done in three wells and one of 
three  similar  series  of experiments  is depicted in the graph.  ,,, 
eEnd.2;  ~,  sEND.l; m, bend.3.  Bar  100 #m. 
cludes that the antibody cross-reacts with mouse P-selectin 
(Fig.  3).  Identical results were obtained in ELISA studies, 
where  microtiter  plates  were  coated with  the  soluble  chi- 
meric proteins which had been purified on protein A-sepha- 
rose (not shown). 
Antibodies against mouse P-selectin were raised by immu- 
nizing rabbits with the soluble, purified P-selectin-IgG~ chi- 
meric protein. The antiserum obtained was affinity purified 
on the fusion protein which had been immobilized to CNBr- 
Figure 2. Immunopreeipitation of E-selectin,  P-selectin,  VCAM-1, 
and ICAM-1 from TNF-activated bEnd.3 and eEnd.2 cells.  Cells 
were metabolically labeled  with [35S]methionine and [35S]cysteine 
for 3 h in the presence and in the absence of TNE Detergent  ex- 
tracts of  bEnd.3 cells (A) and eEnd.2 cells (B) were immunoprecip- 
itated with afffinity-purified  rabbit antibodies  against a peptide con- 
sisting of the 17 COOH-terminal amino acids of mouse ELAM-1 
(A, lanes I and 2), mAb 21KC10 (A, lanes 3 and 4), affinity-purified 
rabbit antibodies  against  a  mouse P-selectin-IgG~  chimeric pro- 
tein (A, lanes 5 and 6), mAb MK-2 (anti VCAM-1) (.4, lanes  7 and 
8), mAb YN 1/1 (anti ICAM-1) (B, lanes I and 2). Immunoprecipi- 
tated proteins  were separated  on 8%  polyacrylamide gels  under 
non-reducing conditions  (A, lanes 1-8) or reducing conditions  (B, 
lanes 1-2) and analyzed by fluorography; relative molecular masses 
(in kD) are marked on the left. 
sepharose. In immunoprecipitations of  metabolically labeled 
bend.3 cells, the purified antibodies specifically recognized 
P-selectin (Fig.  2 A, lane 5). 
ICAM-1, VCAM-1, E-, and P-selectin Are TNF 
Inducible with Distinct Kinetics on the Surface of 
Mouse Endothelioma Cells 
We have tested the TNF inducibility of the four endothelial 
CAMs, ICAM-1, VCAM-1, E-, and P-selectin on the mouse 
endothelioma cells. The effect of TNF-ot on the synthesis of 
these four CAMs was tested in immunoprecipitations  with 
detergent extracts of cells, metabolically labeled for 3 h with 
[35S]methionine and [3~S]cysteine  in the absence or the pres- 
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recognizes the mouse E-selec- 
tin-IgG~  chimeric  protein  in 
immunoblots. 50 ng of  each of 
the  purified  fusion  proteins 
mouse P-selectin-IgG1, mouse 
E-selectin-IgG1  and  CD4- 
IgG1, and of  human IgG1 were 
electrophoresed on a 10% poly- 
acrylamide  gel  under  non- 
reducing conditions  and ana- 
lyzed  in  immunoblot  with 
21KC10 hybridoma  superna- 
tant.  Bound  antibodies  were 
detected with peroxidase con- 
jugated second antibodies; rel- 
ative  molecular  masses  (in 
kD) are indicated on the left. 
ence of TNF-ot. As shown in Fig. 2, TNF-ct strongly stimu- 
lates  the  synthesis  of E-  and  P-selectin  and  VCAM-1  in 
bEnd.3 cells.  ICAM-1, even after stimulation with TNF-ct, 
was only very weakly expressed on bend.3 cells (see below), 
but its synthesis was clearly stimulated on eEnd.2 cells, as 
shown in a separate experiment (Fig. 2). The same result was 
found for send.1  ceils (not shown). 
In "cell-surface ELIS~f' assays, we tested the kinetics of the 
TNF-induced cell surface expression of all four CAMs.  To 
ensure that only antigens on the cell surface were detected, 
monolayers of intact,  unfixed endothelioma cells were in- 
cubated at 4°C with specific antibodies after different time 
periods of stimulation with TNF-ct. The cells were then fixed 
with paraformaldehyde and the first antibodies were detected 
with peroxidase-conjugated second antibodies. 
Cells were stimulated for 0,  2,  4,  8,  16,  and 24 h  with 
TNF-ot  and  the  cell  surface expression  was measured for 
each  antigen  at  each  time point  in  triple  determinations. 
Three independent experiments were performed giving simi- 
lar results.  Fig.  4  shows that both selectins are only tran- 
siently induced with a maximum cell surface expression for 
E-selectin at 4 h and for P-selectin between 4 and 8 h after 
TNF  stimulation.  After 24 h  both selectins are expressed 
near basal levels again. In contrasts, ICAM-1 and VCAM-1 
are slightly less rapidly induced and their cell surface expres- 
sion is still elevated 24 h after activation (Fig. 4). This is con- 
sistent with the time course of cell surface expression that 
was reported for the human homologs on HUVECs, except 
for P-selectin, which has not yet been described to be TNF 
inducible on HUVECs. 
No difference between the three cell lines was found for 
the TNF-induced upregulation of the four CAMs, except that 
ICAM-1  was  only  very  weakly  expressed  on  stimulated 
bend.3 cells and P-selectin was only marginally induced at 
the surface of sEnd.1  cells.  All the CAMs which were up- 
regulated by TNF stimulation on the surface of bEnd.3  or 
send.1  cells, were also upregulated to a similar degree and 
with similar kinetics on eEnd.2 cells. This argues against a 
direct role of these CAMs in the binding to J774 ceils, since 
all four CAMs are present on TNF-stimulated eEnd.2 cells, 
yet J774 cells do not bind (Fig.  1). 
The rapid down regulation of the selectins,  with almost 
basal surface expression on bend.3 and send.1 cells 16 haf- 
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Figure 4. Kinetics of the TNF-cz-induced cell surface  expression  of 
E-selectin,  P-selec~in, 1CAM-I,  and VCAM-1 on three endothe- 
lioma cell lines.  2  x  104 eEnd.2,  sEnd.l,  or bEnd.3  ceils,  cul- 
tured for 2 d in 96-well microtiter plates, were treated for the indi- 
cated time periods with 100 U/ml human recombinant TNF-tx, and 
then  analyzed  by indirect  immunoperoxidase  staining  with  the 
mAbs YN 1/1 (  ....  , anti-ICAM-1), MK-2(---, anti-VCAM-1), KM 
201 (--,  anti-CD44), 21KC10 (--, anti-E-selectin) and affinity- 
purified rabbit antibodies against mouse P-selectin (  ....... ). The 
staining intensity is given in optical density units measured at 492 
nm.  The depicted  experiment  represents  one out  of three  with 
equivalent results. 
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ter the addition of TNF-tx, is an additional argument against 
a role of the selectins in the binding to J774 cells, which bind 
equally well to both endothelial cell lines after 4  and  16 h 
of treatment with TNF-ot (Fig.  1). 
The Cell Surface Appearance of  P-selectin on bEnd.3 
Cells Is Regulated by Two Different Mechanisms 
The TNF-induced synthesis and cell surface appearance of 
P-selectin with maximal expression levels within 4  h  after 
stimulation  is  completely  different  from  the  mechanism, 
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Figure 5. Time course of the cell surface appearance of P-selectin on bEnd.3  cells stimulated by PMA and TNF-~. bEnd.3  ceils were 
cultured as described for Fig. 4 and treated for the indicated time periods with (A) 100 U/ml human recombinant TNF-a ( .... ), 1 #g/ml 
PMA (-.-), (B) 100 U/ml TNF-c~ ( ..... ), a mixture of TNF-c~ plus PMA (  ) with PMA added only for the last 30 min of the 
indicated incubation period with TNF-c~. 
which has been shown to regulate the cell surface appear- 
ance of P-selectin on HUVECs. In these cells, P-selectin is 
stored in the so-called Weibel-Palade-Bodies and becomes 
redistributed to the cell surface within minutes after stimula- 
tion of HUVECs by thrombin, histamine, or phorbolesters. 
We wanted to test whether these two completely different 
regulation mechanisms would both function in the same en- 
dothelial cells. 
To this end, we treated bEnd.3 cells with 1 #g/ml PMA, 
2.5 U/ml thrombin, or 100 U/ml TNF-ot for 5,  15, 30 min, 
and 1, 2, and 4 h before staining the cell surface with poly- 
clonal affinity-purified anti-P-selectin antibodies or the anti- 
E-selectin antibody 21KC10  in indirect immunoperoxidase 
studies.  Control  cells  were  left  unstimulated,  but  were 
treated with the same amount of DMSO present during the 
stimulation with PMA.  Fig.  5 A shows that PMA,  but not 
TNF-a, caused a rapid and transient increase of the P-selec- 
tin signal at the cell surface with a maximum expression level 
after 60 min of treatment with PMA.  The same effect was 
seen with thrombin (not shown) while no such rapid upregu- 
lation was seen on the cell surface expression of E-selectin 
(not shown). In contrast to the PMA effect, TNF-ot induced 
a less rapid increase of P-selectin as well as E-selectin at the 
cell surface, with a maximum after 4 h of stimulation. This 
effect, which is mediated by the de novo synthesis of new 
selectin molecules (Weller et al.,  1992),  was additive with 
the rapid effect, which  was caused by PMA.  Cells which 
were treated with TNF-a for different time periods and in ad- 
dition with PMA for the last 30 min of each time period dis- 
played a higher level of P-selectin on their surface than cells 
which were treated with TNF-o~ alone (Fig. 5 B). Thus, both 
mechanisms can function independently in mouse endothe- 
lioma cells. 
The PMA-induced  increase of the P-selectin signal was 
about half of the maximal increase caused by TNF-a. To test 
whether the TNF-induced, maximal level of cell surface ex- 
pression of P- and E-selectin was similar, we standardized 
the assay by performing ELISA assays on the purified, solu- 
ble forms of P- and E-selectin. Highly activated ELISA mi- 
crotiter  plates  were  saturated  with  affinity-purified  anti- 
human IgGl polyclonal antibodies and incubated with serial 
dilutions  of purified  E-selectin-IgG~ or  P-selectin-IgGl at 
concentrations between 200 ng/ml and 0.1  ng/ml.  Indirect 
immunoperoxidase staining was performed in parallel with 
the ELISA on endothelioma cells, using identical antibody 
solutions and staining parameters. We detected similar levels 
of cell surface expression for E- and P-selectin after maximal 
stimulation by TNF-u. The absolute number of selectin mole- 
cules per cell could not be determined by this assay, since 
100%  binding of selectin chimeras to plastic-coated anti- 
human IgGt antibodies could not be assumed. Since P-selec- 
tin was already constitutively expressed on the cell surface 
at  much  higher  levels  than  E-selectin,  TNF-ot  induction 
caused only a twofold increase of P-selectin at the cell sur- 
face while expression of E-selectin on the cell surface in- 
creased with a factor of 10-15. 
Antibodies, Which Block the Adhesion Function of 
ICAM-1, VCAM-1, E- and P-selectin Do Not Block the 
Binding of  J774 Cells 
J774 cells do not bind to eEnd.2 cells (at 7°C) after 4 and 
16 h of TNF treatment, although E- and P-selectin are clearly 
induced  after 4  h  and ICAM-1  and VCAM-1  are well ex- 
pressed after 16 h  of TNF stimulation.  This indicates that 
none of the four CAMs is directly involved in the binding to 
J774 cells, provided it can be demonstrated that each of these 
CAMs functions at all on eEnd.2  cells in adhesion assays. 
Therefore, we compared the capability of sEnd.l,  bEnd.3, 
and eEnd.2 cells to use each of the four adhesion proteins 
to bind to leukocytes. 






+  L1-2 
aVCD&%-I  aVlk~,.4  -TI~ 
D  IlErtd.1 
+ T1(-1 
CO  ~W.AM-  1  ~LFA-I  .TNF 
_~  *l~ll~  I 
Binding of the B lymphoma line L1-2 to eEnd.2 and sEnd.1 
cells was TNF-c~ dependent (Fig. 6, A and B) and the binding 
efficiency was very low at 7°C (not shown) compared to the 
strong binding at 37°C.  This binding at 37°C was inhibited 
to 53 % by MK-2 (anti-VCAM-1)  and to 45 % by R1-2 (anti- 
c~4) on eEnd.2 cells and to 75% by MK-2 and 63% by R1-2 
on sEnd.1  ceils.  The human B lymphoma line Ramos be- 
haved similarly to L1-2 cells (not shown). 
The  function  of ICAM-1  was  demonstrated  using  the 
mouse T lymphoma TK-1 which binds equally well to send.1 
and eEnd.2 cells after 16 h of TNF-u stimulation (Fig. 6, C 
and D). No, or very weak binding was observed to unstimu- 
lated  cells  and  the  TNF-a-induced  binding  activity  was 
strongly temperature-sensitive, being undetectable at 4-7°C 
and very weak at 20°C (not shown). TK-1 binding could be 
inhibited by 50% with the mAbs YN 1/1 (anti-ICAM-1) and 
M17/4.4.11.9  (anti CDlla) on eEnd.2 cells and by 60-70% 
on sEnd.1  cells. 
The cell adhesion function of E-selectin on bEnd.3  and 
eEnd.2 cells was tested with the human monocytic cell line 
HL60 (Fig. 6, E and F). These cells did not bind to unstimu- 
lated endothelioma cells. Binding was maximal at 4 h after 
TNF-a stimulation, was not temperature sensitive and could 
be performed at 7°C. The antibody 21KC10 blocked HL60 
binding to 4 h-stimulated eEnd.2 and bEnd.3 cells by "~80 
and 70%,  respectively. 
Binding of freshly isolated PMNs from mouse bone mar- 
row to bEnd.3 and eEnd.2 cells (at 7°C) was also TNF de- 
pendent and was partially inhibited by 60% (on eEnd.2) and 
by 33 % (on bEnd.3) with affinity-purified polyclonal rabbit 
anti-P-selectin antibodies (Fig. 6, G and H). Thus, all four 
TNF-inducible cell adhesion molecules were demonstrated 
to be functional on eEnd.2 cells similarly as on bEnd.3 or 
sEnd.1  cells. 
Blocking  of  E-selectin,  P-selectin,  and  VCAM-1  on 
bEnd.3 cells as well as simultaneously blocking all three of 
them with antibodies, did not inhibit the binding of J774 cells 
in adhesion assays performed at 7°C  (Fig.  7).  Binding  of 
J774  cells via high-affinity Fc receptors to the antibodies 
bound to bEnd.3 cells was unlikely since binding was not ob- 
served to these antibodies in similar experiments performed 
with  TNF-activated  eEnd.2  cells  (not  shown).  Since  the 
mAb  YN  1/1  against  ICAM-1  strongly  cross-linked J774 
cells  (which express ICAM-1  on their  surface) to the en- 
dothelioma cells, binding of J774 cells to ICAM-1 was ana- 
lyzed by testing the inhibitory effect of F(at¢)  fragments of 
mAbs against the  leukocyte integrins  LFA-1 (anti-CDlla) 
Figure 6.  Comparison  of the cell adhesion  function of ICAM-1, 
VCAM-1, E- and P-selectin on TNF-activated eEnd-2, sEnd-l, and 
bEnd.3  endothelioma cells. Cell adhesion assays were performed 
as described  under Materials  and Methods with the mouse lym- 
phoma LI-2 (A and B), the mouse T lymphoma TK-1 (C and D), 
the human monocytic cell line HL60 (E and F), and freshly isolated 
PMNs from mouse bone marrow (G, and H) by incubation with 
16-h TNF-stimulated eEnd.2 (A and C) and send.1 cells (B and D) 
and 4-h stimulated eEnd.2  (E and G) and bend.3 cells (F and H). 
Binding to 16-h TNF-stimulated endothelioma cells (A-D) and 4-h 
TNF-stimulated  endothelioma cells (E-H) was defined as 100%. 
Inhibition of cell adhesion with antibodies was tested with  1/100 
diluted ascites of mAb MK-2 (anti-VCAM-1), hybridoma superna- 
tant of mAb R1/2 (anti-VLA-4), 10 txg/ml of purified mAb YN 1/1 
(anti-ICAM-1),  hybridoma  supernatant  of  M17/4 (anti-LFA-1), 
fourfold-concentrated  hybridoma  supernatant  of mAb  21KC10 
(anti-E-selectin),.  and  10  ~g/ml  of affinity-purified rabbit  anti- 
P-selectin  antibodies  (anti-P-selectin).  Antibody  dilutions  were 
done in DME with 10% FCS. Quantitation was done by counting 
the cells under the microscope.  In controls  (Co),  the endothelial 
cells were preincubated with isotype matched mAbs (A-F) or total 
IgG of a rabbit pre-immune antiserum (G and H) at the same con- 
centration as the test antibodies. Absolute numbers of bound leuko- 
cytes to TNF-induced endothelioma cells (taken as 100 % and given 
as ceUs/mm  2) were:  3,511 (A), 2,104  (B),  1,060 (C),  932  (D), 
1,876 (E), 3,756 (F), 2,688 (G), and 4,424 (H). The depicted ex- 
periment represents one out of five with equivalent results. 
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studies on the adhesion ofJ774 
cells  to  16  h  TNF-activated 
bEnd.3  cells,  bEnd.3  cells 
were cultured as described for 
Fig. 4, stimulated with TNF-a 
E  16 h before the assay and incu- 
®  bated with J774 cells. Binding 
under  these  conditions  was 
defined as 100%. Inhibition of 
cell adhesion was tried by in- 
cubating the bend.3 cells with 
1/100 diluted ascites of mAb 
against VCAM-1 (MK-2), four- 
fold concentrated anti-E-selectin hybridoma supernatant (21KC10), 
10 #g/ml of affinity-purified rabbit anti-P-selectin antibodies (903) 
and the mixture of these three antibodies at the same concentration 
(M/x) or by incubating the J774 cells with 100 #g/ml of Fab frag- 
ments of the mAb against CDllb (M1/70) before the cell adhesion 
assay. Quantitation was done by counting the cells under the micro- 
scope. 
(not shown) and Mac-1 (anti-CDllb) (Fig. 7). Both antibod- 
ies did not inhibit the binding of J774 cells at 7°C. 
Since all these antibodies had been found to block adhe- 
sion  of  other  leukocyte  types  to  the  TNF-induced  en- 
dothelioma cells (as described above) these results strongly 
indicate, that the binding of J774 cells to TNF-activated en- 
dothelioma  cells  defines  an  additional,  so  far  unknown 
cytokine-induced  leukocyte  adhesion  mechanism  on  en- 
dothelial cells. 
Comparison of the Function of E- and P-selectin on 
bEnd.3 Cells 
Since both endothelial selectins are known to bind PMNs we 
compared the effect of our antibodies against E- and P-selec- 
tin on the binding of mouse PMNs and HLt0 cells to TNF- 
activated bend.3 endothelioma cells. We found that blocking 
of each selectin alone partially blocked the binding of PMNs 
by  ,030%  (P-selectin)  and  ,020%  (E-selectin),  while  the 
mixture of antibodies against both selectins inhibited PMN 
binding by ,070% (Fig. 8 A). Thus, both antibodies together 
had a more than additive effect. 
Interestingly,  the  binding  of HL60  cells  could  not  be 
blocked by antibodies against P-selectin, even the mixture of 
antibodies against E- and P-selectin did not inhibit cell bind- 
ing  more strongly than  the  mAb against E-selectin alone 
(Fig.  8 B).  Such a lack of HL60 binding to P-selectin has 
also been found by others (Patel et al.,  1991). 
Discussion 
In this study we describe five different TNF-inducible cell ad- 
hesion mechanisms on the surface of mouse endothelioma 
cells. Only for three of  them (ICAM-1, VCAM-1, and E-selec- 
tin) has TNF induction also been demonstrated on human 
endothelial cells. These three CAMs are induced on the sur- 
face of the mouse endothelioma cells with kinetics similar 
to those reported for human primary endothelial cells. 
The fourth TNF-inducible adhesion mechanism is repre- 
sented by P-selectin. We have recently reported that TNF-c~ 
causes  an  increase  of mRNA- and  protein  expression  of 
P-selectin in mouse endothelioma cells (Weller et al., 1992). 
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Figure 8.  Comparison  of the 
inhibitory effect of antibodies 
against  E- and  P-selectin on 
the  binding  of  PMNs  and 
HL60 ceils to TNF activated 
bEnd.3  ceils.  Cell  adhesion 
assays were performed as de- 
scribed  under  Materials  and 
Methods  with  mouse PMNs 
(A) and HL60 cells (B) by in- 
cubation  with 4  h TNF-acti- 
vated bend.3 cells. Cell bind- 
ing in the absence of antibodies 
was defined as 100%. Inhibi- 
tion of cell adhesion with anti- 
bodies  was tested  with four- 
fold concentrated  hybridoma 
supernatant  of mAb 21KC10 
(aE-sel.),  10 gg/ml of  affinity- 
purified rabbit anti-P-selectin 
antibodies  (o~P-sel.), and the 
mixture of both antibodies at 
the same concentrations  (aE- 
sel.  +  aP-sel.).  In controls 
(Co) the endothelial cells were 
incubated with a mixture of a 
control rat IgM hybridoma su- 
pernatant  (fourfold  concen- 
trated) and 10 #g/ml IgG of a 
rabbit pre-immune  serum. 
Here we show that this TNF-induced synthesis of P-selectin 
leads  to a  transient  increase  of P-selectin at the cell  sur- 
face, with kinetics comparable to E-selectin induction. This 
TNF-induced up regulation of P-selectin at the cell surface 
is  functionally  significant,  since  the  binding  of PMNs  to 
TNF-induced endothelioma cells was partially inhibited by 
antibodies against P-selectin. Thus, P-selectin is a true mem- 
ber of the TNF-regulated leukocyte adhesion molecules on 
endothelial cells. 
This new regulation mechanism is different from the one 
that was reported for P-selectin on HUVECs. There, P-selec- 
tin is stored in so-called Weibel-Palade-Bodies. Mobilization 
of these granules to the cell surface and their fusion with the 
plasma membrane can be induced by PMA, thrombin, and 
histamine, causing the cell surface appearance of P-selectin 
within minutes followed by a rapid down regulation (Hattori 
et al.,  1989;  Geng et al.,  1990). 
We report here that  such  a  rapid  induction  mechanism 
also occurs in the mouse endothelioma cells, stimulated by 
PMA and thrombin. Although we have not analyzed whether 
P-selectin is indeed stored also in these cells, it is likely that 
this rapid induction at the cell surface is based on protein 
transport. This regulation mechanism seems to function in- 
dependently of the regulation of the synthesis of P-selectin, 
since the effects of PMA and TNF-ct are additive. This addi- 
tivity, together with the fact that TNF-a itself cannot induce 
the rapid transport of stored intracellular P-selectin to the 
cell surface, may suggest that the TNF induced, newly syn- 
thesized P-selectin molecules directly reach the cell surface, 
thereby circumventing the route via storage granules.  How 
this alternative targeting of P-selectin to storage granules or 
to the plasma membrane is achieved, is still unclear. One ex- 
planation would be, that the TNF-induced newly synthesized 
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tin moieties which are intracellularly stored. However, such 
structural differences would have to be subtle, since the elec- 
trophoretic mobility of  the TNF-induced P-selectin molecules 
was identical to that of the constitutively synthesized mole- 
cules. A more simple explanation for the direct targeting of 
TNF-induced P-selectin to the plasma membrane would be 
to assume, that the capacity of the sorting mechanism which 
targets P-selectin molecules to storage granules is limited 
and that the additionally synthesized molecules are sorted 
into a transport pathway to the cell surface by a default mech- 
anism. 
For a detailed understanding of the physiological role of 
P-selectin, it will be important to know to what extent both 
regulation mechanisms function in vivo. We could demon- 
strate the stimulatory effect of TNF-a on the synthesis of 
P-selectin in mouse tissue by immunoprecipitation analysis 
of metabolically labeled lung tissue of mice, which had been 
intravenously injected with TNF-ot (Weller et al.,  1992). 
Since the endothelium of different types of blood vessels ex- 
press different levels of P-selectin (McEver et al.,  1989), it 
is possible that endothelium with high levels of  stored P-selec- 
tin preferentially regulate the cell surface expression via the 
transport regulation mechanism while other cells with low 
constitutive expression levels might preferentially regulate 
the  synthesis  of P-selectin.  Alternatively, both  regulation 
mechanisms could function in the same cells as is suggested 
by the parallel and independent functioning of both mecha- 
nisms in bEnd.3 cells. 
The  induction  of P-selectin  synthesis  by  a  mechanism 
similar to that of E-selectin further emphasizes the impor- 
tance of analyzing differences and similarities ofthe physio- 
logical role of both endothelial selectins. Since both adhe- 
sion molecules can bind to the tetrasaccharide sialyl-Lewis 
X and both mediate the binding of PMNs and monocytes, the 
function of the endothelial selectins appears to be redundant. 
The rapid transport of P-selectin to the cell surface and the 
more slowly acting up regulation by de novo synthesis of 
E-selectin had served as an explanation for this redundancy, 
arguing for similar functions of both selectins at different 
time points. The parallel expression of both selectins after 
induction  with  TNF-ot,  which  we  have  described,  again 
might argue for redundancy. However, indirect evidence has 
emerged recently, suggesting that the physiological ligands 
for both endothelial selectins on the same leukocytes might 
be different (Larsen et al., 1992). If this is true, the parallel 
expression of both selectins on endothelial cells may allow 
leukocytes to use different ligands to bind to both selectins 
at the same time. Such a multiple interaction might be neces- 
sary to guarantee sufficient strength of the binding of leuko- 
cytes to endothelial cells. 
The lack of HL60-binding to P-selectin, that we found, 
was surprising, since HL60 cells have been shown to bind 
to human P-selectin (Geng et al., 1990; Larsen et al., 1989). 
However, also Patel et al. (1991) could not detect binding of 
their HL60 ceils to P-selectin, although these cells bound to 
E-selectin.  The HL60 cells we used were obtained from 
ATCC and had been subcloned because of initial difficulties 
to propagate them. The resulting subclone apparently had 
lost the ability to bind to P-selectin. Since binding of these 
cells to TNF-activated bEnd.3 ceils could still be inhibited 
by the anti-E-selectin mAb these data suggest that HL60 
cells possess different ligands  for E- and P-selectin.  This 
would be in agreement with data reported by Larsen et al. 
(1992). 
The maximal numbers of P- and E-selectin molecules on 
the cell surface of  bEnd.3 cells after TNF induction are simi- 
lar.  This quantitation was  possible,  since the cell surface 
ELISA  signals  could be  standardized  by assays  with  the 
purified E- and P-selectin-IgG fusion proteins.  P-selectin 
was clearly detectable at the cell surface in the absence of 
any stimulation in contrast to E-selectin which was only very 
weakly expressed under such conditions.  Because of this 
high constitutive expression level of P-selectin, TNF-o~ only 
causes a twofold increase of the amount of P-selectin at the 
cell surface. It is known that such differences in adhesion 
molecule expression of around two- to threefold are func- 
tionally significant (Dustin and Springer, 1991; Pardi et al., 
1992). In agreement with this, we observed P-selectin-medi- 
ated binding of PMNs only to TNF-induced endothelioma 
ceils.  A  situation similar to P-selectin was also found for 
ICAM-1  which  is  constitutively expressed on sEnd.1  and 
eEnd.2 cells and is also stimulated in its cell surface expres- 
sion only two- to threefold by TNF-ot. 
The fifth TNF-inducible cell adhesion mechanism on the 
surface of sEnd.1 and bEnd.3 endothelioma cells is defined 
by  the  binding  of the  mouse  monocytic/macrophage cell 
line J774.  We can exclude that ICAM-1,  VCAM-1,  E-, or 
P-selectin mediate this binding  for the following reasons: 
First,  adhesion-blocking antibodies against all four CAMs 
do not interfere with the binding of J774 cells. Second, J774 
cells do not bind to TNF-induced eEnd.2 cells, yet all four 
CAMs are TNF inducible to a similar degree on eEnd.2 as 
on sEnd.1 and bend.3 cells, and all four CAMs can be dem- 
onstrated to function in cell adhesion assays on eEnd.2 cells. 
Third, the induction kinetics of E- and P-selectin is different 
from the kinetics for the new binding mechanism: J774 cells 
bind equally well after 4 and 16 h of TNF stimulation while 
E- and P-selectin are clearly down regulated again after 16 h. 
Fourth,  binding  of J774  ceils  occurs  at  low  temperature 
(4-7°C)  where  ICAM-1  and  VCAM-1  hardly  bind  their 
known integrin ligands. We conclude that the binding of  J774 
cells to mouse endothelioma ceils is mediated by a TNF- 
inducible adhesion mechanism which is possibly new and 
which functions well at low temperature. 
New TNF-inducible cell adhesion mechanisms have also 
been  described  on  human  endothelial  cells.  On  human 
dermis microvasculature-derived endothelial cells, a TNF- 
inducible  binding  mechanism  for  melanoma  cells  was 
defined, which could only partially be blocked by antibodies 
against VCAM-1,  did not correlate with the expression of 
ICAM-1 and ELAM-1 and which was not found on HUVECs 
(Lee et al., 1992). Vennegoor et al. (1992) reported the bind- 
ing of cultured human T cell clones to 24-h TNF-a-stimu- 
lated HUVECs which could not significantly be blocked by 
antibodies against human ICAM-1, VCAM-1, and E-selectin. 
The T cell clones which were used in the assays did not ex- 
press L-selectin on their surface and the cell binding assays 
were carried out at 37°C. In contrast, Spertini et al. (1991) 
have demonstrated the binding of lymphocytes and neutro- 
phils to 24-h TNF-a-activated HUVECs at 4°C. This bind- 
ing could be inhibited with anti-L-selectin antibodies. It is 
unlikely that this mechanism is related to the one we have 
found to mediate the binding of J774 cells, since we did not 
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FACS analysis (not shown). 
Clearly, more TNF-inducible leukocyte adhesion mole- 
cules exist on endothelial cells than have yet been character- 
ized on the molecular level. The mouse endothelioma cells 
have proved to be useful in identifying P-selectin as a new 
member of this group of cell adhesion molecules. By using 
the same mAb approach which we successfully used here to 
obtain the mAb 21KC10 against mouse E-selectin, we should 
be able to identify the  novel cytokine-inducible adhesion 
mechanism, which supports the binding of J774 cells. 
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